文献速递耳科与耳神经小儿耳鼻咽喉

1990至2019年全球、区域及国家层面中耳炎疾病负担:一项基于人群的研究

Global, Regional, and National Burdens of Otitis Media From 1990 to 2019: A Population Based Study.
PubMed 文献 · Ear Hear · 2024-01-05

该研究基于2019年全球疾病负担研究,评估1990至2019年全球中耳炎的患病率、发病率、死亡率、伤残调整寿命年率及平均年度百分比变化。全球中耳炎患病率、伤残调整寿命年和死亡率均持续下降,发病率在2000年引入7价肺炎球菌结合疫苗后急剧下降并持续下降;2019年1至4岁儿童发病率最高,为每10万人29,127.3例。

要点

  • 1990至2019年全球中耳炎患病率、伤残调整寿命年和死亡率均持续下降。
  • 2000至2009年全年龄发病率年平均下降1.2%,2010至2019年继续下降0.2%。
  • 2019年1至4岁儿童发病率最高,为每10万人29,127.3例;30岁以下年轻成人占发病病例的91.3%。

核心结论

  • 全球在降低中耳炎所致伤残调整寿命年和死亡率方面已取得成效。
  • 2000年引入7价肺炎球菌结合疫苗后全球中耳炎发病率急剧下降,随后采用13价肺炎球菌结合疫苗或肺炎球菌不可分型流感嗜血杆菌蛋白D结合疫苗后下降趋势持续。
  • 持续开展中耳炎全球趋势、病原体分布和耐药模式的流行病学监测仍然至关重要。

研究设计与样本

  • 基于2019年全球疾病负担研究,评估1990至2019年全球地理人群中耳炎的患病率、发病率、死亡率、伤残调整寿命年率及平均年度百分比变化。
  • 按年龄、性别和社会人口指数进行亚组分析全球趋势。

主要发现

  • 全球全年龄患病率平均年度百分比变化为-0.7(95%CI -0.7至-0.8),伤残调整寿命年为-1.0(95%CI -1.1至-1.0),死亡率为-6.8(95%CI -7.3至-6.4),1990至2019年间持续下降。
  • 全年龄发病率在2000至2009年间急剧下降,平均年度百分比变化为-1.2(95%CI -1.4至-0.9),2010至2019年继续下降趋势,平均年度百分比变化为-0.2(95%CI -0.3至-0.1)。
  • 2019年1至4岁儿童发病率最高,为每10万人29,127.3例;30岁以下年轻成人占发病病例的91.3%。
  • 1990至2019年中低收入国家发病率增幅最大,平均年度百分比变化为0.3(95%CI 0.3至0.3);发病率和伤残调整寿命年随社会人口指数升高而下降。
  • 区域上1990至2019年发病率增幅最大的是高收入亚太地区、东欧和撒哈拉以南非洲西部;国家层面大韩民国发病率增幅最大,平均年度百分比变化为0.8(95%CI 0.6至1.1)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Otitis media is one of the most important causes of hearing loss at an early age. Effective vaccination with the routine 7-valent pneumococcal conjugate vaccine (PCV-7) was introduced in 2000. It has been gradually replaced by the pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine or the higher-valent 13-valent PCV (PCV-13) since 2010. Data on the change in otitis media burden in recent years are sparse at the global, regional, and national levels. DESIGN: The Global Burden of Disease 2019 study was used to evaluate the prevalence, incidence, mortality, disability-adjusted life year (DALY) rates, and the average annual percentage changes (AAPCs) in otitis media in geographic populations worldwide from 1990 to 2019. These global trends were further analyzed by subgroup (age, sex, and sociodemographic index [SDI]). RESULTS: Globally, the all-age rate of prevalence (AAPC = -0.7, 95% confidence interval [CI] = -0.7 to -0.8), DALYs (AAPC = -1.0, 95% CI = -1.1 to -1.0), and mortality (AAPC = -6.8, 95% CI = -7.3 to -6.4) from otitis media decreased constantly between 1990 and 2019. The all-age rate of incidence decreased sharply between 2000 and 2009 with an AAPC of -1.2 (95% CI = -1.4 to -0.9) and continued the downward trend between 2010 and 2019 (AAPC = -0.2, 95% CI = -0.3 to -0.1). In 2019, children aged 1 to 4 years old had the highest incidence at 29,127.3 per 100,000 population, while young adults under 30 years old accounted for 91.3% of the incident cases. Individuals living in middle-SDI countries had the largest increase in the incidence of otitis media, with an AAPC of 0.3 (95% CI = 0.3 to 0.3) between 1990 and 2019. The incidence and DALYs from otitis media decreased with increasing SDI. Regionally, the largest increase in incidence was observed in high-income Asia Pacific, Eastern Europe, and Western Sub-Saharan Africa between 1990 and 2019. Nationally, the largest increase in the incidence of otitis media was observed in the Republic of Korea, with an AAPC of 0.8 (95% CI = 0.6 to 1.1) in the same time period. CONCLUSIONS: There have been successful previous endeavors to reduce DALYs and mortality attributed to otitis media on a global scale. The worldwide incidence of otitis media experienced a sharp decline following the introduction of PCV-7 in 2000, and this downward trend persisted in subsequent years with the adoption of PCV-13/pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine. Continual epidemiological surveillance of otitis media's global trends, pathogen distribution, and resistance patterns remains imperative.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Jin Y, Yang X, Sun H, et al. Global, Regional, and National Burdens of Otitis Media From 1990 to 2019: A Population Based Study. Ear Hear. 2024. PMID: 38178304. doi:10.1097/AUD.0000000000001453

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。